About the Authors

Barney S. Graham

bgraham@nih.gov

Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

M. Juliana McElrath

Affiliation Fred Hutchinson Cancer Research Center, University of Washington at Seattle, Seattle, Washington, United States of America

Michael C. Keefer

Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

Kyle Rybczyk

Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

David Berger

Affiliation Fred Hutchinson Cancer Research Center, University of Washington at Seattle, Seattle, Washington, United States of America

Kent J. Weinhold

Affiliation Duke University School of Medicine, Durham, North Carolina, United States of America

Janet Ottinger

Affiliation Duke University School of Medicine, Durham, North Carolina, United States of America

Guido Ferarri

Affiliation Duke University School of Medicine, Durham, North Carolina, United States of America

David C. Montefiori

Affiliation Duke University School of Medicine, Durham, North Carolina, United States of America

Don Stablein

Affiliation EMMES Corporation, Rockville, Maryland, United States of America

Carol Smith

Affiliation EMMES Corporation, Rockville, Maryland, United States of America

Richard Ginsberg

† Deceased.

John Eldridge

Affiliation Profectus Biosciences, Inc., Tarrytown, New York, United States of America

Ann Duerr

Affiliation Fred Hutchinson Cancer Research Center, University of Washington at Seattle, Seattle, Washington, United States of America

Pat Fast

Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America

Barton F. Haynes

Affiliation Duke University School of Medicine, Durham, North Carolina, United States of America

the AIDS Vaccine Evaluation Group

Competing Interests

Barton F. Haynes was involved in the conceptual development of the peptide vaccine. Neither the EMMES Corporation nor Profectus Biosciences have competing intellectual or financial interests related to the products discussed in this manuscript. All the authors agree to adhere to the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: BSG MJM MCK KW JO GF DCM DS CS PF BFH. Performed the experiments: BSG MJM MCK KR DB KW JO GF DCM BFH. Analyzed the data: BSG MJM MCK KW JO GF DCM DS CS AD PF BFH. Contributed reagents/materials/analysis tools: BSG MJM KW JO GF DCM DS CS RG JE BFH. Wrote the paper: BSG MCK KR DB KW DS CS AD PF BFH.